—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Abivax SA (ABVX.PA) — Technical state

As of 2026-11-10 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 38 out of 100 (momentum 18 · quality 53 · valuation 56), as of 2026-11-11.
  • Signal: Downtrend stack — Trades -5.6% vs the 50-day and -18.2% vs the 200-day average, 42.2% below the 52-week high and +32.8% off the 52-week low; a death cross printed 33 sessions ago. Computed from daily closes. (as of 2026-11-10)
  • Trend: Abivax SA trades 5.6% below its 50-day and 18.2% below its 200-day moving average. (as of 2026-11-10)

Abivax is a clinical-stage biotechnology company based in Paris that develops therapies aimed at calming the body's own immune response in chronic inflammatory disease. Its lead candidate, obefazimod, is in Phase 3 development for ulcerative colitis and in Phase 2b trials for Crohn's disease.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the ABVX.PA overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Downtrend stack

Trades -5.6% vs the 50-day and -18.2% vs the 200-day average, 42.2% below the 52-week high and +32.8% off the 52-week low; a death cross printed 33 sessions ago. Computed from daily closes.

The moving-average stack

Continue: the ABVX.PA chart & overview · quality & forensics · the signal board

FAQ · from the current data · as of 2026-11-10

Quick answers

What is the current Closelooknet signal on ABVX.PA?

Downtrend stack — Trades -5.6% vs the 50-day and -18.2% vs the 200-day average, 42.2% below the 52-week high and +32.8% off the 52-week low; a death cross printed 33 sessions ago. Computed from daily closes. As of 2026-11-10; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is ABVX.PA above its 50-day and 200-day moving averages?

As of 2026-11-10, Abivax SA trades -5.6% below its 50-day and -18.2% below its 200-day average, with the 20-day +0.8% away.

How far is ABVX.PA from its 52-week high?

42.2% below the 52-week high and 32.8% above the 52-week low, as of 2026-11-10.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.